MEXICO CITY, Oct. 23, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise mentioned. Comments from Genomma's CEO, Marco Sparvieri "Genomma delivered a strong third quarter, with a 15.9% Net Sales increase, an 82% EPS increase to Ps. 0.66, and EBITDA margin expanding to 23.7% for the quarter; a 245 basis-point increase driven by our productivity initiatives' continued progress. Lower CAPEX coupled with an increased EBITDA margin resulted in a record-high free cash flow of Ps. 2.4 billion for the trailing twelve months, reflecting a 68% increase.